HK Stock Market Move | CNBM (03323) rises over 4% in the morning, planning to cooperate with Jilin Yatai to develop overseas markets. The company is advancing its strategy of outward development.
China Building Materials (03323) rose more than 4% in the morning. As of the time of drafting, it rose by 4.06% to HK$5.13, with a turnover of HK$52.6231 million.
CNBM (03323) rose by more than 4% in the morning session, rising by 4.06% to HK$5.13 by the time of publication, with a turnover of HK$52.62 million.
On the news front, on December 16, Zhou Yuxian, Secretary of the Party Committee and Chairman of CNBM Group, met with Chen Tiezhi, Secretary of the Party Committee and Chairman of Jilin Yatai at the group's headquarters. Zhou Yuxian stated that the two sides can continue to deepen industrial synergy, with CNBM willing to provide systematic solutions for Jilin Yatai's transformation and upgrade of basic building materials, actively expand cooperation in new materials and other areas, and jointly develop overseas markets to create a new chapter of high-quality development.
On December 18, Zhou Yuxian, Secretary of the Party Committee and Chairman of CNBM Group, and his team conducted a research and guidance visit to Sinoma International Engineering. Zhou Yuxian listened to a work report from Yang Lei, General Manager of Sinoma International Engineering, and a supplementary report on the "14th Five-Year" strategic development plan of Sinoma International Engineering, as well as the development of green energy business and mineral development. GF SEC stated that this research and exchange reflect the company's expected efforts in mineral development and green energy business, strengthening the implementation of an expansion-oriented development strategy. It is expected to increase the company's profits and contribute to value reshaping in the future.
Related Articles

LEADS BIOLABS-B(09887): LBL-047 medication for the first subject in Phase I trial.

Kuaishou-W (01024): Strongly condemn illegal criminal activities of the black and grey industries, have reported to the public security organs and relevant departments.

HAICHANG HLDG (02255) signs a strategic cooperation memorandum with Henan Provincial Science and Technology Museum.
LEADS BIOLABS-B(09887): LBL-047 medication for the first subject in Phase I trial.

Kuaishou-W (01024): Strongly condemn illegal criminal activities of the black and grey industries, have reported to the public security organs and relevant departments.

HAICHANG HLDG (02255) signs a strategic cooperation memorandum with Henan Provincial Science and Technology Museum.

RECOMMEND





